Revolutionizing Pain Relief with Cutting-Edge Treatments
QC Kinetix is redefining the future of regenerative medicine by offering advanced, non-surgical solutions for joint and musculoskeletal pain. Established in 2017, this rapidly expanding company has built a presence in over 100 cities across the U.S., treating thousands of patients with its groundbreaking therapies.
Harnessing the body’s natural regenerative abilities, QC Kinetix provides innovative treatment options that improve mobility, reduce discomfort, and eliminate the need for invasive surgery.
In May 2024, QC Kinetix secured a spot among Entrepreneur’s Top 10 New and Emerging Franchises, ranking at No. 9 due to its impressive unit growth, financial stability, and brand strength. Over the past three years, the company achieved a remarkable 2,111% increase in unit growth, cementing its reputation as an industry leader.
“We’re honored to be recognized among the fastest-growing franchise brands,” stated the CEO of QC Kinetix. “This achievement is a reflection of our team’s dedication and commitment to transforming the regenerative medicine industry.”
Industry Experts and Elite Athletes Back QC Kinetix
With a mission to provide a superior alternative to traditional pain management, QC Kinetix helps patients regain their quality of life without relying on medication, steroids, or surgery. The company’s innovative biologics treatment protocols have successfully transformed the lives of thousands.
Renowned orthopedic surgeon Dr. Mitchell Sheinkop recently joined QC Kinetix as National Medical Director, bringing over 37 years of expertise in joint replacement surgery. His decision to partner with the company underscores his belief in regenerative medicine’s potential. Dr. Sheinkop will lead medical advancements, enhance treatment protocols, and integrate physical therapy and weight loss strategies into patient care. His leadership will further solidify QC Kinetix’s position as a pioneer in the field.
Additionally, Pro Football Hall of Famer Emmitt Smith serves as the brand’s national spokesperson.
“I’ve got to keep taking care of these joints,” Smith shared. “When I take QC Kinetix’s natural supplements, it’s like—bam—Emmitt 2.0. Sometimes, you need a competitive edge.”
The Origins and Vision of QC Kinetix
Founded by a team of medical professionals and business visionaries, QC Kinetix was created to challenge conventional musculoskeletal pain treatments.
The name QC Kinetix reflects its roots in Charlotte, North Carolina (Queen City, QC) and its mission to restore motion and function—a play on the term kinetic energy.
Unlike traditional methods that rely on insurance-driven treatments, QC Kinetix developed a concierge medical model focused on cutting-edge regenerative medicine. Their patient-centered approach provides safe, effective, and minimally invasive solutions for those seeking alternatives to surgery and pharmaceuticals.
“No longer did we want insurance companies dictating treatment options,” explained a company spokesperson. “We wanted research to guide our protocols, ensuring the best possible outcomes for patients—whether insurance covered it or not.”
By prioritizing patient needs over insurance constraints, QC Kinetix is revolutionizing the industry, positioning itself as the first choice for pain relief rather than a last resort.
A Patient-First Approach to Regenerative Medicine
As a leader in regenerative medicine, QC Kinetix offers comprehensive, biologically based treatments to help individuals maintain active lifestyles. Their therapies harness the body’s natural healing properties, providing effective, non-invasive alternatives to surgery and addictive pain medications.
Patients seek treatment for a variety of conditions, including knee, hip, and shoulder pain. QC Kinetix’s regenerative therapies restore function and mobility, significantly improving patients’ overall quality of life.
In 2023, QC Kinetix surpassed $100 million in system-wide sales. By April 2024, the company had treated over 40,000 patients since launching its nationwide expansion in 2021.
“Our goal is to redefine medicine,” said the CEO of QC Kinetix. “We want to be the first thought when people experience pain. The real success is in the feedback from patients whose lives we’ve transformed.”
QC Kinetix Poised for Global Expansion
With an established presence in the U.S., QC Kinetix is setting its sights on international markets, including the United Kingdom, Australia, and New Zealand.
By the end of 2024, the company aims to operate 250 clinics across the United States, marking a monumental milestone in its journey.
Despite the rapid expansion, the CEO of QC Kinetix believes the company could have grown even faster given the rising demand for non-surgical pain relief solutions.
“This brand has an incredible future,” the CEO emphasized. “It’s about changing lives and leading the way in regenerative medicine.”